Ditchcarbon
  • Contact
  1. Organizations
  2. Evolus, Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 2 months ago

Evolus, Inc. Sustainability Profile

Company website

Evolus, Inc., a prominent player in the aesthetic industry, is headquartered in the United States and operates across key regions globally. Founded in 2012, the company has rapidly established itself as a leader in non-surgical aesthetic treatments, focusing primarily on innovative products that enhance beauty and confidence. Evolus is best known for its flagship product, Jeuveau, a neuromodulator designed specifically for aesthetic use, which sets itself apart through its unique formulation and targeted marketing approach. The company has achieved significant milestones, including rapid market penetration and recognition for its commitment to quality and safety in aesthetic procedures. With a strong market position, Evolus continues to expand its portfolio, aiming to redefine the aesthetic experience for consumers and practitioners alike. Its dedication to innovation and customer satisfaction has solidified its reputation as a trusted name in the beauty industry.

DitchCarbon Score

How does Evolus, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

25

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Evolus, Inc.'s score of 25 is lower than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.

39%

Let us know if this data was useful to you

Evolus, Inc.'s reported carbon emissions

Evolus, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Consequently, there are no documented Scope 1, 2, or 3 emissions to analyse. Furthermore, the company has not established any formal reduction targets or commitments, including those aligned with the Science Based Targets initiative (SBTi). This lack of data suggests that Evolus, Inc. may still be in the early stages of developing its climate strategy or reporting framework. As the industry increasingly prioritises sustainability, Evolus, Inc. may need to consider implementing climate commitments and reduction initiatives to align with best practices and stakeholder expectations.

How Carbon Intensive is Evolus, Inc.'s Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Evolus, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Evolus, Inc.'s Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Evolus, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Evolus, Inc.'s Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Evolus, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Evolus, Inc.'s Emissions with Industry Peers

Merz Pharma GmbH & Co. KGaA

DE
•
Pharmaceutical Preparation Manufacturing
Updated 17 days ago

InMode Ltd.

IL
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 17 days ago

The Beauty Health Company

US
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 17 days ago

Bausch Health Cos

CA
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Sinclair Pharma Limited

GB
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Abbvie

US
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251119.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
Available onAWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy